Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The investigator initiated Phase I trial of ADRCs (Cytori Cell Therapy™) in the patients with post radical prostatectomy erectile dysfunction

Trial Profile

The investigator initiated Phase I trial of ADRCs (Cytori Cell Therapy™) in the patients with post radical prostatectomy erectile dysfunction

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Jul 2018

At a glance

  • Drugs ECCS 50 (Primary)
  • Indications Erectile dysfunction
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Jul 2018 Results presented in a Cytori Therapeutics Media Release.
    • 09 Jul 2018 According to a Cytori Therapeutics Media Release, 12-month data from this study were published in the Journal of Urology.
    • 18 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top